by stemcellclub | Oct 26, 2026 | Stem Cell Therapy
Research Spotlight · Spinal Cord Injury On October 15, 2026, an expert panel in Japan endorsed full approval of Stemirac, a stem cell product for spinal cord injury. It would be the first product in Japan to move from conditional approval to full approval. Here is...
by stemcellclub | Oct 23, 2026 | Stem Cell Therapy
Research Spotlight · Aging & Frailty Can a stem cell infusion help frail older adults walk farther? A 148-person placebo-controlled trial, published in Cell Stem Cell in 2026, is the strongest attempt yet to find out. The results are interesting. They are also...
by stemcellclub | Oct 21, 2026 | Stem Cell Therapy
Research Spotlight · Multiple Sclerosis A stem cell transplant for multiple sclerosis is no longer a fringe idea. It has a randomized trial behind it, European treatment recommendations, and three more randomized trials racing toward results. It is also chemotherapy,...
by stemcellclub | Oct 19, 2026 | Stem Cell Therapy
Research Spotlight · Clinical Trial A stem cell–derived dopamine neuron therapy for Parkinson’s is now in a Phase 3 trial with a sham-surgery control group. Four-year Phase 1 data were just presented in October 2026. Here is what the early numbers show, why the...
by stemcellclub | Oct 16, 2026 | Stem Cell Therapy
Research Spotlight · Clinical Trial A heart-derived cell therapy for Duchenne muscular dystrophy just got published in The Lancet and is sitting at the FDA with a November 2026 decision date. The company says the Phase 3 trial worked. The FDA’s own briefing says...